Clinical Trial Update: Effects of Maraviroc vs. Efavirenz on CD4/CD8 Ratio [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing maraviroc to efavirenz in HIV/AIDS assessing CD4/CD8 ratio after treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• EFAVIRENZ (efavirenz)
• Maraviroc (maraviroc)

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: HIV/AIDS | Phase 3 | Status: COMPLETED